{
  "nct_id": "NCT31748253",
  "indication": "Non-Small Cell Lung Cancer",
  "phase": "Phase 2",
  "sample_size": 89,
  "duration_weeks": 114,
  "dropout_rate": 0.4,
  "blinding": "single-blind",
  "control_arm": "active comparator",
  "primary_endpoints": [
    "Overall survival"
  ],
  "secondary_endpoints": [
    "Progression-free survival",
    "Objective response rate"
  ],
  "outcome_summary": "Statistically significant clinical benefit observed",
  "success": 1,
  "start_date": "2018-07-09",
  "completion_date": "2020-09-14"
}